---
title: "Workflow for single cell RNA seq"
author: 
  - name: Author Name1
    affiliation: Address of author1
  - name: Author Name2
    affiliation: Address of author2
abstract: Abstracts should be up to 300 words and provide a succinct summary of the article. Although the abstract should explain why the article might be interesting, care should be taken not to inappropriately over-emphasise the importance of the work described in the article. Citations should not be used in the abstract, and the use of abbreviations should be minimized.
keywords: Please list up to eight keywords to help readers interested in your article find it more easily.
bibliography: sample.bib
output: 
    BiocStyle::html_document:
        fig_caption: yes
vignette: >
    %\VignetteIndexEntry{worfklow}
    %\VignetteEngine{knitr::rmarkdown}
---


# Introduction


*The introduction provides context as to why the software tool was developed and what need it addresses.  It is good scholarly practice to mention previously developed tools that address similar needs, and why the current tool is needed.*

We propose a worklow for single cell RNA-Seq.

```{r frog-picture, out.width='90%', fig.align='center', fig.cap = 'Our workflow'}
knitr::include_graphics('workflow.png')
```


# Steps of the workflow

Along the worflow, use deviance residuals as adjusted values. The steps of our worflow are as follow

## Dimensionality reduction

zinbwave


## Cluster cells 

clusterExperiment

## Get lineage

slingshot

## Get DE genes

edgeR



# Results <!-- Optional - only if novel data or analyses are included -->
This section is only required if the paper includes novel data or analyses, and should be written as a traditional results section.

# Use Cases <!-- Optional - only if NO new datasets are included -->
This section is required if the paper does not include novel data or analyses. 
Examples of input and output files should be provided with some explanatory context.  Any novel or complex variable parameters should also be explained in sufficient detail to allow users to understand and use the tool's functionality.

# Discussion <!-- Optional - only if novel data or analyses are included -->
This section is only required if the paper includes novel data or analyses, and should be written in the same style as a traditional discussion section.
Please include a brief discussion of allowances made (if any) for controlling bias or unwanted sources of variability, and the limitations of any novel datasets.


# Conclusions <!-- Optional - only if novel data or analyses are included -->
This section is only required if the paper includes novel data or analyses, and should be written as a traditional conclusion.

# Summary <!-- Optional - only if NO new datasets are included -->
This section is required if the paper does not include novel data or analyses.  It allows authors to briefly summarize the key points from the article.

# Data availability <!-- Optional - only if novel data or analyses are included -->
Please add details of where any datasets that are mentioned in the paper, and that have not have not previously been formally published, can be found.  If previously published datasets are mentioned, these should be cited in the references, as per usual scholarly conventions.

# Software availability
This section will be generated by the Editorial Office before publication. Authors are asked to provide some initial information to assist the Editorial Office, as detailed below.

1. URL link to where the software can be downloaded from or used by a non-coder (AUTHOR TO PROVIDE; optional)
2. URL link to the author's version control system repository containing the source code (AUTHOR TO PROVIDE; required)
3. Link to source code as at time of publication (*F1000Research* TO GENERATE)
4. Link to archived source code as at time of publication (*F1000Research* TO GENERATE)
5. Software license (AUTHOR TO PROVIDE; required)


# Author contributions
In order to give appropriate credit to each author of an article, the individual
contributions of each author to the manuscript should be detailed in this section. We
recommend using author initials and then stating briefly how they contributed.

# Competing interests
All financial, personal, or professional competing interests for any of the authors that
could be construed to unduly influence the content of the article must be disclosed and will be displayed alongside the article. If there are no relevant competing interests to declare, please add the following: 'No competing interests were disclosed'.

# Grant information
Please state who funded the work discussed in this article, whether it is your employer, a grant funder etc. Please do not list funding that you have that is not relevant to this
specific piece of research. For each funder, please state the funderâ€™s name, the grant
number where applicable, and the individual to whom the grant was assigned.
If your work was not funded by any grants, please include the line: 'The author(s)
declared that no grants were involved in supporting this work.'

# Acknowledgments
This section should acknowledge anyone who contributed to the research or the
article but who does not qualify as an author based on the criteria provided earlier
(e.g. someone or an organization that provided writing assistance). Please state how
they contributed; authors should obtain permission to acknowledge from all those
mentioned in the Acknowledgments section.

Please do not list grant funding in this section.


